Algalif plans $30M expansion for its astaxanthin facilities
Algalif Iceland is undergoing a US$30 million expansion plan for its sustainable astaxanthin production facilities in Iceland. The investment will more than triple the company's production.
Orri Björnsson, Algalif CEO. Image courtesy of Algalif
Algalif Iceland is undergoing a US$30 million expansion plan for its sustainable astaxanthin production facilities in Iceland. Production will more than triple from 1,500 kg to 5,000 kg of astaxanthin annually once the new facility opens in 2022.
“This is one of the biggest foreign investment projects in Iceland for a while,” said Orri Björnsson, Algalif CEO, in a press release. Construction will begin early next year, and the increase in production will make Algalif the biggest astaxanthin producer in the world, according to the company. Already known for production quality and delivery security in addition to a knowledgeable management team and competitive cost structure, Algalif experiences the best year in their company history in 2020, selling all their production that year, and for 2021.
During the construction period, more than 100 new local jobs will be created. From 2023, permanent jobs will double from 35, currently, to 70 employees.
OmniActive partners with CRN to raise awareness about macular carotenoids for prenatal health
May 6th 2024OmniActive Health Technologies has announced a partnership with the Council for Responsible Nutrition to educate and raise awareness about the role of lutein and zeaxanthin in supporting maternal and fetal health during pregnancy among obstetricians, gynecologists, and other maternal healthcare practitioners.
What's next for NPA and CRN in their complaints against New York state?
May 2nd 2024The latest updates in the efforts of the Natural Products Association and the Council for Responsible Nutrition to sue New York state for its law banning the sale of weight management and muscle building supplements to minors.
